Cargando…
What is synergy? The Saariselkä agreement revisited
Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of syn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555011/ https://www.ncbi.nlm.nih.gov/pubmed/26388771 http://dx.doi.org/10.3389/fphar.2015.00181 |
_version_ | 1782388114090622976 |
---|---|
author | Tang, Jing Wennerberg, Krister Aittokallio, Tero |
author_facet | Tang, Jing Wennerberg, Krister Aittokallio, Tero |
author_sort | Tang, Jing |
collection | PubMed |
description | Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of synergy. Two popular reference models for null hypothesis include the Bliss independence model and the Loewe additivity model, each of which is formulated from different perspectives. During the last century, there has been an intensive debate on the suitability of these synergy models, both of which are theoretically justified and also in practice supported by different schools of scientists. More than 20 years ago, there was a community effort to make a consensus on the terminology one should use when claiming synergy. The agreement was formulated at a conference held in Saariselkä, Finland in 1992, stating that one should use the terms Bliss synergy or Loewe synergy to avoid ambiguity in the underlying models. We review the theoretical relationships between these models and argue that one should combine the advantages of both models to provide a more consistent definition of synergy and antagonism. |
format | Online Article Text |
id | pubmed-4555011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45550112015-09-18 What is synergy? The Saariselkä agreement revisited Tang, Jing Wennerberg, Krister Aittokallio, Tero Front Pharmacol Pharmacology Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of synergy. Two popular reference models for null hypothesis include the Bliss independence model and the Loewe additivity model, each of which is formulated from different perspectives. During the last century, there has been an intensive debate on the suitability of these synergy models, both of which are theoretically justified and also in practice supported by different schools of scientists. More than 20 years ago, there was a community effort to make a consensus on the terminology one should use when claiming synergy. The agreement was formulated at a conference held in Saariselkä, Finland in 1992, stating that one should use the terms Bliss synergy or Loewe synergy to avoid ambiguity in the underlying models. We review the theoretical relationships between these models and argue that one should combine the advantages of both models to provide a more consistent definition of synergy and antagonism. Frontiers Media S.A. 2015-09-01 /pmc/articles/PMC4555011/ /pubmed/26388771 http://dx.doi.org/10.3389/fphar.2015.00181 Text en Copyright © 2015 Tang, Wennerberg and Aittokallio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Tang, Jing Wennerberg, Krister Aittokallio, Tero What is synergy? The Saariselkä agreement revisited |
title | What is synergy? The Saariselkä agreement revisited |
title_full | What is synergy? The Saariselkä agreement revisited |
title_fullStr | What is synergy? The Saariselkä agreement revisited |
title_full_unstemmed | What is synergy? The Saariselkä agreement revisited |
title_short | What is synergy? The Saariselkä agreement revisited |
title_sort | what is synergy? the saariselkä agreement revisited |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555011/ https://www.ncbi.nlm.nih.gov/pubmed/26388771 http://dx.doi.org/10.3389/fphar.2015.00181 |
work_keys_str_mv | AT tangjing whatissynergythesaariselkaagreementrevisited AT wennerbergkrister whatissynergythesaariselkaagreementrevisited AT aittokalliotero whatissynergythesaariselkaagreementrevisited |